Concomitant Gastric Acid Suppressants on the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Meta-Analysis

BACKGROUND: The influence of concomitant use of gastric acid suppressants (AS) on survival of patients with non-small-cell lung cancer (NSCLC) treated with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is inconsistent according to previous studies. We performed a meta-ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Jun, Zhu, Jiping, Li, Lei, Xu, Shiqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159195/
https://www.ncbi.nlm.nih.gov/pubmed/35685507
http://dx.doi.org/10.1155/2022/3102641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159195/
https://www.ncbi.nlm.nih.gov/pubmed/35685507
http://dx.doi.org/10.1155/2022/3102641

Ejemplares similares